BPTHOTCPharmaceutical PreparationsFiscal year ends December 31
BIO-PATH HOLDINGS, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.80K
- P/E (TTM)
- –
- Dividend yield
- –
BIO-PATH HOLDINGS, INC. revenue by segment
By business segment
By product or service
By region
From the segment and revenue-disaggregation notes of Bio-Path's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.